V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002206 | 210008159 | 0 | 62.7 | Neo-adjuvant (N) | 2016-01-13 | 2016-04-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100923093 |
| 210002207 | 210008160 | 1.64 | 71 | Adjuvant (A) | 2016-01-05 | 2016-03-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100576952 |
| 210002212 | 210008163 | 1.61 | 112 | Adjuvant (A) | 2016-05-17 | 2016-10-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100347829 |
| 210002213 | 210008164 | 1.7 | 84.4 | Disease modification (D) | 2019-09-22 | 2020-12-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100408370 |
| 210002214 | 210008165 | 1.65 | 74 | Adjuvant (A) | 2018-05-29 | 2018-06-27 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101532797 |
| 210002215 | 210008166 | 1.63 | 85 | Adjuvant (A) | null | 2019-06-22 | Trastuzumab | 02 | N | TRASTUZUMAB | 100696132 |
| 210002216 | 210008167 | 1.68 | 58 | Adjuvant (A) | 2019-04-19 | 2019-07-14 | PACLITAXEL | null | N | PACLITAXEL | 101282180 |
| 210002219 | 210008169 | null | 83.4 | Palliative (P) | 2019-06-02 | 2019-08-28 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101461123 |
| 210002221 | 210008171 | 1.55 | 76.2 | null | 2019-01-11 | 2019-03-30 | Docetaxel | null | null | DOCETAXEL | 101125890 |
| 210002222 | 210008172 | 1.58 | null | null | 2019-05-21 | 2019-09-02 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100996739 |
| 210002223 | 210008173 | 1.64 | null | null | 2019-12-12 | 2020-01-09 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101536125 |
| 210002224 | 210008174 | 1.72 | 59.8 | null | 2021-05-10 | 2021-05-25 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101014321 |
| 210002225 | 210008175 | null | null | Curative (C) | 2019-10-19 | 2019-10-25 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 101808767 |
| 210002226 | 210008176 | 1.75 | null | Adjuvant (A) | 2018-12-06 | 2019-02-14 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101469952 |
| 210002228 | 210008178 | 1.63 | 84.4 | Neo-adjuvant (N) | 2019-05-17 | 2019-09-09 | Docetaxel | 2 | N | DOCETAXEL | 100034181 |
| 210002229 | 210008179 | null | null | null | 2019-02-12 | 2019-04-18 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101584469 |
| 210002231 | 210008181 | 1.75 | 56.4 | null | null | 2018-09-30 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100346740 |
| 210002232 | 210008182 | 1.72 | 109.3 | Adjuvant (A) | 2018-07-04 | 2018-10-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100284759 |
| 210002233 | 210008183 | null | 93.8 | Palliative (P) | null | 2019-05-29 | Docetaxel | N | null | DOCETAXEL | 101778974 |
| 210002234 | 210008184 | 1.74 | 53.9 | Neo-adjuvant (N) | null | 2021-06-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101690020 |
| 210002237 | 210008185 | 1.61 | null | Adjuvant (A) | null | 2021-06-20 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100804275 |
| 210002238 | 210008186 | 1.7 | 56 | Palliative (P) | 2018-08-14 | 2018-11-14 | Docetaxel | null | N | DOCETAXEL | 101513901 |
| 210002239 | 210008187 | 1.69 | 92.8 | Adjuvant (A) | 2016-05-16 | 2017-08-02 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100277023 |
| 210002242 | 210008189 | 1.62 | 97.7 | Neo-adjuvant (N) | 2016-11-07 | 2017-02-12 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100285307 |
| 210002243 | 210008190 | 1.59 | 69.2 | Adjuvant (A) | 2017-04-02 | 2017-06-17 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101871161 |
| 210002246 | 210008192 | 1.57 | 83.6 | Adjuvant (A) | 2016-04-26 | 2016-08-10 | Paclitaxel 7 day | N | N | PACLITAXEL | 100470498 |
| 210002248 | 210008193 | 1.62 | 78.3 | Palliative (P) | 2017-03-20 | 2017-03-20 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101242814 |
| 210002253 | 210008196 | 1.62 | 62.6 | Adjuvant (A) | 2019-08-15 | 2020-10-22 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100112206 |
| 210002256 | 210008197 | 1.44 | 54 | Adjuvant (A) | null | 2019-12-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100276757 |
| 210002257 | 210008198 | 1.67 | 69 | Adjuvant (A) | null | 2018-02-04 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100732879 |
| 210002258 | 210008199 | 1.69 | 65.6 | Adjuvant (A) | 2019-09-25 | 2019-12-19 | Trastuzumab | N | N | TRASTUZUMAB | 101767361 |
| 210002260 | 210008201 | null | 84.9 | Adjuvant (A) | 2019-12-12 | 2020-03-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101555067 |
| 210002261 | 210008202 | 1.75 | 62.2 | Palliative (P) | 2018-06-04 | 2018-06-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100016034 |
| 210002262 | 210008203 | 1.52 | 63.6 | Adjuvant (A) | 2018-10-04 | 2018-10-19 | Docetaxel | null | N | DOCETAXEL | 101201429 |
| 210002263 | 210008204 | null | 77.6 | Neo-adjuvant (N) | 2017-07-24 | 2017-07-24 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100038099 |
| 210002264 | 210008205 | 1.57 | 94.7 | Adjuvant (A) | null | 2017-03-22 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100552978 |
| 210002265 | 210008206 | 1.62 | 64 | Palliative (P) | 2022-02-26 | 2022-05-09 | Docetaxel | null | N | DOCETAXEL | 101019613 |
| 210002267 | 210008207 | 1.63 | 62.6 | Adjuvant (A) | 2021-08-14 | 2021-08-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101763255 |
| 210002268 | 210008208 | 1.65 | 75.5 | Palliative (P) | null | 2018-08-25 | Docetaxel | 01 | null | DOCETAXEL | 101265629 |
| 210002269 | 210008209 | null | 69 | null | 2019-03-11 | 2019-06-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100405966 |
| 210002270 | 210008210 | 1.53 | 55 | Palliative (P) | 2016-12-19 | 2017-01-31 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100957857 |
| 210002273 | 210008212 | 1.63 | 68.4 | Adjuvant (A) | 2018-09-09 | 2020-01-14 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100673297 |
| 210002283 | 210008218 | 0 | 119 | Palliative (P) | null | 2016-08-06 | EC | 2 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101747615 |
| 210002284 | 210008219 | 1.51 | 61.3 | Adjuvant (A) | 2016-12-02 | 2016-12-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100680766 |
| 210002286 | 210008221 | 1.49 | 62 | Adjuvant (A) | null | 2018-08-18 | PACLITAXEL | 02 | N | PACLITAXEL | 101122143 |
| 210002287 | 210008222 | 1.6 | 86.4 | Adjuvant (A) | null | 2017-06-19 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100583150 |
| 210002289 | 210008224 | null | 105 | null | 2017-09-20 | 2019-05-07 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100369860 |
| 210002290 | 210008225 | null | 60.9 | Neo-adjuvant (N) | 2018-11-16 | 2018-11-30 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100735481 |
| 210002291 | 210008226 | 1.58 | 103.5 | Adjuvant (A) | null | 2019-02-28 | Trastuzumab | 02 | N | TRASTUZUMAB | 101058090 |
| 210002293 | 210008227 | 1.73 | 83.1 | Adjuvant (A) | null | 2018-12-27 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101590197 |